NOV/CCN3 Upregulates CCL2 and CXCL1 expression in astrocytes through β1 and β5 integrins

GLIA

Volumn 58, Issue 12, 2010, Pages 1510-1521

  Le Dreau G ^a,b,e   Kular, L ^a,b   Nicot, A B ^b,c   Calmel, C ^a,b   Melik Parsadaniantz, S ^b,d   Kitabgi, P ^a,b   Laurent, M ^a,b   Martinerie, C ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Astrocyte reactivity; CCL2; Chemokines; CXCL1; Integrins; MAPK; NF B; NOV CCN3; Rho ROCK

Indexed keywords

ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA5 INTEGRIN; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RHO KINASE; STRESS ACTIVATED PROTEIN KINASE; BETA INTEGRIN; ENZYME INHIBITOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; ANTIGENS, CD29; ASTROCYTES; BRAIN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL1; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTEGRIN BETA CHAINS; MALE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 77956609028     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21025     Document Type: Article

References (77)

1. Albrecht C, von Der Kammer H, Mayhaus M, Klaudiny J, Schweizer M, Nitsch RM. 2000. Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61. J Biol Chem 275:28929-28936.
2. Banisadr G, Gosselin RD, Mechighel P, Kitabgi P, Rostene W, Parsadaniantz SM. 2005. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: Evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 489:275-292.
3. Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, Scarpini E, Bresolin N, Wharton SB, Shaw PJ, Silani V. 2005. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32:541-544.
4. Bertollini C, Ragozzino D, Gross C, Limatola C, Eusebi F. 2006. Fractalkine/ CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 51:816-821.
5. Calderwood DA. 2004. Integrin activation. J Cell Sci 117:657-666.
6. Calhabeu F, Lafont J, Le Dréau G, Laurent M, Kazazian C, Schaeffer L, Martinerie C, Dubois C, 2006. NOV/CCN3 impairs muscle cell commitment and differentiation. Exp Cell Res1876-1889.
7. Cammarano MS, Minden A. 2001. Dbl and the Rho GTPases activate NF kappa B by I kappa B kinase (IKK)-dependent and IKK-independent pathways. J Biol Chem 276:25876-25882. (Pubitemid 37412791)
8. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374.
9. Chen CC, Lau LF. 2009. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41:771-783.
10. Chen CC, Young JL, Monzon RI, Chen N, Todorovic V, Lau LF. 2007. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J 26:1257-1267.
11. de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP. 2007. Neuronal chemokines: Versatile messengers in central nervous system cell interaction. Mol Neurobiol 36:137-151.
12. Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S, West AN, Laurent M, Mas JC, Bongain A, Zambetti GP, Figueiredo BC, Auberger P, Martinerie C, Lalli E. 2007. Nephroblastoma overexpressed/ cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J Clin Endocrinol Metab 92:3253-3260.
13. Ellis PD, Chen Q, Barker PJ, Metcalfe JC, Kemp PR. 2000. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 20:1912-1919. (Pubitemid 30644640)
14. Flugel A, Hager G, Horvat A, Spitzer C, Singer GM, Graeber MB, Kreutzberg GW, Schwaiger FW. 2001. Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab 21:69-76.
15. Garcia-Segura LM, Naftolin F, Hutchison JB, Azcoitia I, Chowen JA. 1999. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol 40:574-584.
16. Ghosh S, Hayden MS. 2008. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8:837-848.
17. Giffard RG, Swanson RA. 2005. Ischemia-induced programmed cell death in astrocytes. Glia 50:299-306. (Pubitemid 40780836)
18. Gosselin RD, Dansereau MA, Pohl M, Kitabgi P, Beaudet N, Sarret P, Melik Parsadaniantz S. 2008. Chemokine network in the nervous system: A new target for pain relief. Curr Med Chem 15:2866-2875.
19. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR. 2001. Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54:293-299.
20. Gupta R, Hong D, Iborra F, Sarno S, Enver T. 2007. NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 316:590-593.
21. Hahn C, Orr AW, Sanders JM, Jhaveri KA, Schwartz MA. 2009. The subendothelial extracellular matrix modulates JNK activation by flow. Circ Res 104:995-1003.
22. Heath E, Tahri D, Andermarcher E, Schofield P, Fleming S, Boulter CA. 2008. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol 8:18-35.
23. Heesen M, Tanabe S, Berman MA, Yoshizawa I, Luo Y, Kim RJ, Post TW, Gerard C, Dorf ME. 1996. Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. J Neurosci Res 45:382-391.
24. Henneberger C, Papouin T, Oliet SH, Rusakov DA. 2010. Long-term potentiation depends on release of D-serine from astrocytes. Nature 463:232-236.
25. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B. 1992. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:10-21.
26. Karadag A, Zhou M, Croucher PI. 2006. ADAM-9 (MDC-9/meltringamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin. Blood 107:3271-3278.
27. Katayama T, Tanaka H, Yoshida T, Uehara T, Minami M. 2009. Neuronal injury induces cytokine-induced neutrophil chemoattractant-1 (CINC-1) production in astrocytes. J Pharmacol Sci 109:88-93.
28. Klein S, de Fougerolles AR, Blaikie P, Khan L, Pepe A, Green CD, Koteliansky V, Giancotti FG. 2002. Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation. Mol Cell Biol 22:5912-5922.
29. Kocialkowski S, Yeger H, Kingdom J, Perbal B, Schofield PN. 2001. Expression of the human NOV gene in first trimester fetal tissues. Anat Embryol (Berl) 203:417-427. (Pubitemid 32662532)
30. Lafont J, Jacques C, Le Dréau G, Calhabeu F, Thibout H, Dubois C, Berenbaum F, Laurent M, Martinerie C. 2005a. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen. J Bone Miner Res 20:2213-2223.
31. Lafont J, Laurent M, Thibout H, Lallemand F, Le Bouc Y, Atfi A, Martinerie C. 2002. The expression of novH in adrenocortical cells is down-regulated by TGFbeta 1 through c-Jun in a Smad-independent manner. J Biol Chem 277:41220-41229.
32. Lafont J, Thibout H, Dubois C, Laurent M, Martinerie C. 2005b. NOV/ CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival. Cell Commun Adhes 12:41-57. (Pubitemid 43135475)
33. Lal H, Verma SK, Smith M, Guleria RS, Lu G, Foster DM, Dostal DE. 2007. Stretch-induced MAP kinase activation in cardiac myocytes: Differential regulation through beta1-integrin and focal adhesion kinase. J Mol Cell Cardiol 43:137-147.
34. Laurent M, Martinerie C, Thibout H, Hoffman M, Verrecchia F, Le Bouc Y, Mauviel A, Kleinman H. 2003. NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha- dependent mechanism. FASEB J 17:1919-1921.
35. Le Dréau G, Nicot A, Bénard M, Thibout H, Vaudry D, Martinerie C, Laurent M. 2010. NOV/CCN3 promotes maturation of cerebellar granule neuron precursors. Mol Cell Neurosci 43:60-71.
36. Leveille C, Bouillon M, Guo W, Bolduc J, Sharif-Askari E, El-Fakhry Y, Reyes-Moreno C, Lapointe R, Merhi Y, Wilkins JA, Mourad W. 2007. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling. J Biol Chem 282:5143-5151.
37. Liao JK, Seto M, Noma K. 2007. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50:17-24.
38. Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF. 2005. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): Implication in wound healing. J Biol Chem 280:8229-8237.
39. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY, Lau LF. 2003. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200-24208. (Pubitemid 36830256)
40. Liu C, Liu XJ, Crowe PD, Kelner GS, Fan J, Barry G, Manu F, Ling N, De Souza EB, Maki RA. 1999. Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene 238:471-478.
41. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354-1357. (Pubitemid 33063104)
42. McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE. 2009. CCN3: A key growth regulator in chronic myeloid leukaemia. J Cell Commun Signal 3:115-124.
43. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
44. Meng SZ, Oka A, Takashima S. 1999. Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Dev 21:30-35.
45. Miranti CK, Brugge JS. 2002. Sensing the environment: A historical perspective on integrin signal transduction. Nat Cell Biol 4:E83-90.
46. Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan- Moyal E, Toulas C. 2008. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer 123:357-364.
47. O'Neill LA. 2006. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov 5:549-563.
48. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
49. Prat A, Biernacki K, Wosik K, Antel JP. 2001. Glial cell influence on the human blood-brain barrier. Glia 36:145-155. (Pubitemid 33055903)
50. Ribaux P, Ehses JA, Lin-Marq N, Carrozzino F, Boni-Schnetzler M, Hammar E, Irminger JC, Donath MY, Halban PA. 2007. Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin- 1 in rat pancreatic beta-cells. Endocrinology 148:5582-5590.
51. Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC. 2009. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174:1725-1734.
52. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18:10457-10463.
53. Rossi D, Volterra A. 2009. Astrocytic dysfunction: Insights on the role in neurodegeneration. Brain Res Bull 80:224-232.
54. Rostene W, Kitabgi P, Parsadaniantz SM. 2007. Chemokines: A new class of neuromodulator? Nat Rev Neurosci 8:895-903.
55. Rydziel S, Stadmeyer L, Zanotti S, Durant D, Smerdel-Ramoya A, Canalis E. 2007. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem 282:19762-19772.
56. Sakamoto K, Yamaguchi S, Ando R, Miyawaki A, Kabasawa Y, Takagi M, Li C, Perbal B, Katsube K. 2002. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem 277:29399-29405.
57. Semple BD, Kossmann T, Morganti-Kossmann MC. 2010. Role of chemokines in CNS health and pathology: A focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab 30:459-473.
58. Shaik SS, Soltau TD, Chaturvedi G, Totapally B, Hagood JS, Andrews WW, Athar M, Voitenok NN, Killingsworth CR, Patel RP, Fallon MB, Maheshwari A. 2009. Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinase-p38β MAPK-NF-κB pathway. J Biol Chem 284:5945-5955.
59. Shimizu S, Tahara M, Ogata S, Hashimoto K, Morishige K, Tasaka K, Murata Y. 2007. Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells. Mol Hum Reprod 13:181-187.
60. Skuli N, Monferran S, Delmas C, Favre G, Bonnet J, Toulas C, Cohen- Jonathan Moyal E. 2009. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: A novel pathway for hypoxia regulation in glioblastoma. Cancer Res 69:3308-3316.
61. Song H, Stevens CF, Gage FH. 2002. Astroglia induce neurogenesis from adult neural stem cells. Nature 417:39-44. (Pubitemid 34498810)
62. Su BY, Cai WQ, Zhang CG, Martinez V, Lombet A, Perbal B. 2001. The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol 54:184-191.
63. Tawil NJ, Wilson P, Carbonetto S. 1994. Expression and distribution of functional integrins in rat CNS glia. J Neurosci Res 39:436-447. (Pubitemid 24348298)
64. Thibout H, Martinerie C, Créminon C, Godeau F, Boudou P, Le Bouc Y, Laurent M. 2003. Characterization of human NOV in biological fluids: An enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. J Clin Endocrinol Metab 88:327-336. (Pubitemid 36115185)
65. Thompson WL, Van Eldik LJ. 2009. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFkappaB and MAPK dependent pathways in rat astrocytes. Brain Res 1287:47-57.
66. Ubogu EE, Cossoy MB, Ransohoff RM. 2006. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27:48-55.
67. Valles A, Grijpink-Ongering L, de Bree FM, Tuinstra T, Ronken E. 2006. Differential regulation of the CXCR2 chemokine network in rat brain trauma: Implications for neuroimmune interactions and neuronal survival. Neurobiol Dis 22:312-322.
68. Van Eldik LJ, Thompson WL, Ralay Ranaivo H, Behanna HA, Martin Watterson D. 2007. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: Function-based and target-based discovery approaches. Int Rev Neurobiol 82:277-296.
69. Wang J, Fan J, Laschinger C, Arora PD, Kapus A, Seth A, McCulloch CA. 2005. Smooth muscle actin determines mechanical force-induced p38 activation. J Biol Chem 280:7273-7284.
70. Wang Y, Luo W, Reiser G. 2007. The role of calcium in protease-activated receptor-induced secretion of chemokine GRO/CINC-1 in rat brain astrocytes. J Neurochem 103:814-819. (Pubitemid 47498036)
71. Watanabe Y, Tamura M, Osajima A, Anai H, Kabashima N, Serino R, Nakashima Y. 2003. Integrins induce expression of monocyte chemoattractant protein-1 via focal adhesion kinase in mesangial cells. Kidney Int 64:431-440.
72. Wen-Xin L, Martinerie C, Zumkeller W, Westphal M, Perbal B. 1996. Differential expression of novH and CTGF in human glioma cell lines. J Clin Pathol Mol Pathol 49:M91-97.
73. White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, Steflik J, Cortright DN, Lamotte RH, Miller RJ. 2005. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA 102:14092-14097. (Pubitemid 41377708)
74. Wolter S, Doerrie A, Weber A, Schneider H, Hoffmann E, von der Ohe J, Bakiri L, Wagner EF, Resch K, Kracht M. 2008. c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol Cell Biol 28:4407-4423.
75. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloid- beta in vitro and in situ. Nat Med 9:453-457.
76. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. 2004. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10:2072-2081. (Pubitemid 38375569)
77. Zhang J, De Koninck Y. 2006. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem 97:772-783.